Within the lymphocyte population, the B cell number in the peripheral blood of VRP-FLT3 vaccinated tumor-bearing mice was increased significantly on day 28 compared to that of the mice receiving PBS or VRP-Ctrl vaccines (Figure 4B). Here, FLT3 is linked to neoplasm.